SCHEMBL399550

SCHEMBL399550

COC(=O)c1cc(C)c(O)c(C(=O)OC)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.57
GAA P10253 2/20 0.57
XDH P47989 2/20 0.57
TDP1 Q9NUW8 2/20 0.57
LMNA P02545 2/20 0.57
POLB P06746 1/20 0.57
NFKB1 P19838 1/20 0.57
GFER P55789 1/20 0.57
NFKB2 Q00653 1/20 0.57
RELA Q04206 1/20 0.57
FUT7 Q11130 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
CA12 O43570 5/20 0.53
CA1 P00915 5/20 0.53
CA2 P00918 5/20 0.53
CA7 P43166 5/20 0.53
CA9 Q16790 5/20 0.53
CA14 Q9ULX7 5/20 0.53
CNR2 P34972 1/20 0.46
ESR1 P03372 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL402330 0.88 CA12 (0.54) KDM4EGAAXDHTDP1LMNA
SCHEMBL5161494 0.88 KDM4E (0.65) KDM4EGAAXDHTDP1LMNA
SCHEMBL198717 0.88 KDM4E (0.65) KDM4EGAAXDHTDP1LMNA
SCHEMBL24592969 0.86 KDM4E (0.50) KDM4EGAAXDHTDP1LMNA
SCHEMBL3353446 0.82 LMNA (0.77) KDM4EGAAXDHTDP1LMNA
SCHEMBL8395371 0.82 GAA (0.45) KDM4EGAAXDHTDP1LMNA
SCHEMBL23796581 0.82 CYP3A4 (0.56) KDM4EGAAXDHTDP1LMNA
SCHEMBL13779473 0.82 CA1 (0.50) KDM4EGAAXDHTDP1LMNA
SCHEMBL15958202 0.82 CA12 (0.50) KDM4EGAAXDHTDP1LMNA
SCHEMBL21854475 0.81 KDM4E (0.57) KDM4EGAAXDHTDP1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
EP-1803452-A1 ESTER DERIVATIVE AND PHARMACEUTICAL USE THEREOF Japan Tobacco, Inc. (JP) 2007-07-04 EP disclosed
US-20060089392-A1 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089392-A1 Ester derivatives and medicinal use thereof MTTP, CETP, LIPA KDM4E 2908/4885GAA 312/4885XDH 1927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.